Stock overview
Johnson & Johnson
Explore the company, reported ownership, price history, and available source evidence.
Johnson & Johnson develops medicines and medical technology products.
- Last close
- $272.70
- · JNJ
- Tracked holders
- 5 funds
- Latest available 13F per fund
JNJ · USD
Price
Close · Nov 18, 2026
- Range low
- $142.06
- Range high
- $285.75
- Observations
- 1255
- Session date
- Nov 18, 2026
Nov 18, 2021–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Markel Group largest tracked holder Q3 2026 · filed Oct 30, 2026 · SEC filing | — | $161,703,191 | 1.26% |
| Gotham Asset Management position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +2% 26'Q3 | $54,109,150 | 0.11% |
| Central Securities position history Q3 2026 · filed Nov 6, 2026 · SEC filing | — | $18,531,800 | 1.33% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $10,027,292 | 0.01% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+15% 26'Q2 | $6,711,944 | 0.15% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market